does it matter where i inject semaglutide Ozempic Injection Sites: Abdomen vs Thigh vs Arm How to Inject Semaglutide (Step-by-Step

Home News and Events Commentary A Snapshot of the Semaglutide Patent Landscape A Snapshot of the Semaglutide Patent Landscape Obesity affects over 1.9 billion people worldwide

as of 2026 lands in these ranges: Semaglutide (Wegovy): $1,100 to $1,400 per month at retail Tirzepatide (Zepbound): $1,000 to $1,300 per month at retail Sermorelin (compounded): $200 to $400 per month at a licensed clinic CJC-1295 + Ipamorelin (compounded): $250 to $450 per month Insurance coverage for Wegovy and Zepbound has improved in 2026 but remains inconsistent

The incidence varies between different products and doses, with constipation listed as 'very common' (affecting more than 1 in 10 people) with Wegovy and Saxenda, and 'common' (affecting up to 1 in 10 people) with Ozempic, Trulicity and Mounjaro

It might help patients shed more weight than anything currently on the market

Results vary based on individual factors and adherence to lifestyle modifications

Exenatide The FDA OKd exenatide in 2005, making it the first approved GLP-1 for Type 2 diabetes